VMD

Q4 Revenue Performance: Viemed reported Q4 revenue of $60.7 million, surpassing estimates of $59.4 million, with CEO Casey Hoyt highlighting strong organic growth and profitability while improving operational metrics.

Market Confidence: The company emphasizes its value in providing complex respiratory services amid a regulatory environment focused on efficiency and compliance, which enhances confidence in their business model.

Financial Forecast: Viemed Healthcare anticipates an adjusted EBITDA of $54 million to $58 million for FY25.

Investment Insights: The article highlights the importance of thorough investment research, including stock risk assessments and competitor analysis, to optimize investment decisions.

Major Earnings Announcements: Key companies reporting earnings after the market close on Monday include Oracle Corporation, Asana, Limbach Holdings, Vail Resorts, and Lineage Cell Therapeutics.

Additional Earnings Releases: Other companies set to release their earnings include CHRS, FTK, GECC, LFMD, MC, MYO, RDW, and YALA.

U.S. Stock Futures: U.S. stock futures rose this morning, with the Dow futures increasing by over 100 points, despite J.B. Hunt Transport Services reporting weaker-than-expected earnings, causing its shares to drop 10.3% in pre-market trading.

Other Stocks Performance: Several other stocks also saw declines in pre-market trading, including Alumis Inc., MiMedx Group, and JetBlue Airways, with drops ranging from 3.4% to 8.8%.

U.S. Stock Market Trends: U.S. stock futures are down, with Dow futures dropping over 100 points; several companies, including Ingles Markets and Viemed Healthcare, reported declines in pre-market trading.

Notable Stock Movements: Ingles Markets saw a 1.2% decrease in shares after reporting lower net sales, while other stocks like Evotec SE and Tesla also experienced notable declines in pre-market trading.

Market Overview: U.S. stock futures showed a slight increase, with Nasdaq futures up by 0.2%, while several stocks, including Super Micro Computer, experienced significant declines in pre-market trading due to capital raising concerns.

Stock Performance: Super Micro Computer shares dropped 12.5% to $31.85, alongside other notable declines from companies like Tile Shop Holdings and KalVista Pharmaceuticals, which fell 11.5% and 7.9% respectively.

Financial Performance: Viemed Healthcare reported a Q3 GAAP EPS of $0.10, exceeding expectations by $0.03, with revenue reaching $58 million, a 17.4% year-over-year increase that also surpassed estimates by $0.85 million.

Adjusted EBITDA Growth: The company's adjusted EBITDA for the quarter ending September 30, 2024, rose by 15.5% to $14 million, indicating positive financial momentum and growth in ventilator patient numbers.

Earnings Report: Viemed Healthcare reported Q2 2024 earnings per share of 4 cents, missing the analyst estimate of 7 cents, and revenue of $50.74 million, which was below the expected $53.80 million.

Automated Coverage: InvestorPlace Earnings utilizes automated data from TradeSmith to quickly provide key financial figures and comparisons to analyst estimates without human intervention.

• Viemed Healthcare's Q1 2024 GAAP EPS was $0.04, missing the estimated $0.07.
• Sales for Q1 2024 were $50.593 million, surpassing the estimated $50.000 million.